BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Menshikh A, Scarfe L, Delgado R, Finney C, Zhu Y, Yang H, de Caestecker MP. Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis. Am J Physiol Renal Physiol 2019;317:F1383-97. [PMID: 31509009 DOI: 10.1152/ajprenal.00366.2019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 De La Cruz LK, Yang X, Menshikh A, Brewer M, Lu W, Wang M, Wang S, Ji X, Cachuela A, Yang H, Gallo D, Tan C, Otterbein L, de Caestecker M, Wang B. Adapting decarbonylation chemistry for the development of prodrugs capable of in vivo delivery of carbon monoxide utilizing sweeteners as carrier molecules. Chem Sci 2021;12:10649-54. [PMID: 34447558 DOI: 10.1039/d1sc02711e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
2 Lan S, Yang B, Migneault F, Turgeon J, Bourgault M, Dieudé M, Cardinal H, Hickey MJ, Patey N, Hébert MJ. Caspase-3-dependent peritubular capillary dysfunction is pivotal for the transition from acute to chronic kidney disease after acute ischemia-reperfusion injury. Am J Physiol Renal Physiol 2021;321:F335-51. [PMID: 34338031 DOI: 10.1152/ajprenal.00690.2020] [Reference Citation Analysis]
3 Antoine M, Husson C, Yankep T, Mahria S, Tagliatti V, Colet J, Nortier J. Protective Effect of Nebivolol against Oxidative Stress Induced by Aristolochic Acids in Endothelial Cells. Toxins 2022;14:132. [DOI: 10.3390/toxins14020132] [Reference Citation Analysis]
4 Naved BA, Bonventre JV, Hubbell JA, Hukriede NA, Humphreys BD, Kesselman C, Valerius MT, McMahon AP, Shankland SJ, Wertheim JA, White MJV, de Caestecker MP, Drummond IA. KIDNEY REPAIR AND REGENERATION: PERSPECTIVES OF THE NIDDK (RE)BUILDING A KIDNEY CONSORTIUM. Kidney Int 2022:S0085-2538(22)00183-1. [PMID: 35276204 DOI: 10.1016/j.kint.2022.02.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hukriede NA, Soranno DE, Sander V, Perreau T, Starr MC, Yuen PST, Siskind LJ, Hutchens MP, Davidson AJ, Burmeister DM, Faubel S, de Caestecker MP. Experimental models of acute kidney injury for translational research. Nat Rev Nephrol 2022. [PMID: 35173348 DOI: 10.1038/s41581-022-00539-2] [Reference Citation Analysis]
6 Nakano D. Septic acute kidney injury: a review of basic research. Clin Exp Nephrol 2020;24:1091-102. [PMID: 32783173 DOI: 10.1007/s10157-020-01951-3] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hu X, Ma Z, Wen L, Li S, Dong Z. Autophagy in Cisplatin Nephrotoxicity during Cancer Therapy. Cancers (Basel) 2021;13:5618. [PMID: 34830772 DOI: 10.3390/cancers13225618] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lee H, Ji SY, Hwangbo H, Kim MY, Kim DH, Park BS, Park JH, Lee BJ, Kim GY, Jeon YJ, Choi YH. Protective Effect of Gamma Aminobutyric Acid against Aggravation of Renal Injury Caused by High Salt Intake in Cisplatin-Induced Nephrotoxicity. Int J Mol Sci 2022;23:502. [PMID: 35008928 DOI: 10.3390/ijms23010502] [Reference Citation Analysis]
9 Li S, Wen L, Hu X, Wei Q, Dong Z. HIF in Nephrotoxicity during Cisplatin Chemotherapy: Regulation, Function and Therapeutic Potential. Cancers (Basel) 2021;13:E180. [PMID: 33430279 DOI: 10.3390/cancers13020180] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Katagiri D, Wang F, Gore JC, Harris RC, Takahashi T. Clinical and experimental approaches for imaging of acute kidney injury. Clin Exp Nephrol 2021;25:685-99. [PMID: 33835326 DOI: 10.1007/s10157-021-02055-2] [Reference Citation Analysis]
11 Kida Y. Peritubular Capillary Rarefaction: An Underappreciated Regulator of CKD Progression. Int J Mol Sci 2020;21:E8255. [PMID: 33158122 DOI: 10.3390/ijms21218255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tan R, Li J, Liu J, Lei X, Zhong X, Wang C, Yan Y, Linda Ye L, Darrel Duan D, Lan H, Wang L. BAY61‐3606 protects kidney from acute ischemia/reperfusion injury through inhibiting spleen tyrosine kinase and suppressing inflammatory macrophage response. FASEB j 2020;34:15029-46. [DOI: 10.1096/fj.202000261rrr] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zhu Z, Hu J, Chen Z, Feng J, Yang X, Liang W, Ding G. Transition of acute kidney injury to chronic kidney disease: role of metabolic reprogramming. Metabolism 2022;:155194. [PMID: 35346693 DOI: 10.1016/j.metabol.2022.155194] [Reference Citation Analysis]
14 Basile DP. The case for capillary rarefaction in the AKI to CKD progression: insights from multiple injury models. American Journal of Physiology-Renal Physiology 2019;317:F1253-4. [DOI: 10.1152/ajprenal.00468.2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Najar-Acosta LJ, Robles-Murillo AK, León-Moreno LC, Desentis-Desentis MF, García-Espinoza JA, Barba-Gutiérrez JP, Romero-Gómez AG, Del Toro-Arreola A, Daneri-Navarro A, Topete-Camacho A, Franco-Topete RA, Sánchez-Zubieta FA, Zepeda-Moreno A, Rivas-Carrillo JD. Establishment of Murine Model of Kidney Failure Induced by Severe Ischemia-Reperfusion Injury Useful to Evaluate Transplantation and Regenerative Therapies. Transplant Proc 2020;52:1202-5. [PMID: 32164959 DOI: 10.1016/j.transproceed.2020.02.014] [Reference Citation Analysis]
16 Spencer S, Wheeler-Jones C, Elliott J. Hypoxia and chronic kidney disease: Possible mechanisms, therapeutic targets, and relevance to cats. Vet J 2021;274:105714. [PMID: 34252550 DOI: 10.1016/j.tvjl.2021.105714] [Reference Citation Analysis]
17 Doreille A, Azzi F, Larivière-Beaudoin S, Karakeussian-Rimbaud A, Trudel D, Hébert MJ, Dieudé M, Patey N, Cardinal H. Acute Kidney Injury, Microvascular Rarefaction, and Estimated Glomerular Filtration Rate in Kidney Transplant Recipients. Clin J Am Soc Nephrol 2021;16:415-26. [PMID: 33648972 DOI: 10.2215/CJN.07270520] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Julovi SM, Sanganeria B, Minhas N, Ghimire K, Nankivell B, Rogers NM. Blocking thrombospondin-1 signaling via CD47 mitigates renal interstitial fibrosis. Lab Invest 2020;100:1184-96. [PMID: 32366943 DOI: 10.1038/s41374-020-0434-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
19 Shi M, Maique J, Shepard S, Li P, Seli O, Moe OW, Hu MC. In vivo evidence for therapeutic applications of beclin 1 to promote recovery and inhibit fibrosis after acute kidney injury. Kidney Int 2021:S0085-2538(21)01028-0. [PMID: 34736972 DOI: 10.1016/j.kint.2021.09.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]